Rapid Dose Therapeutics Corp. (DOSE.CN)
CAD 0.18
(-10.0%)
CAD 0.18
(-10.0%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -0.04 CAD | -11.11% |
| 2022 | -0.04 CAD | 71.62% |
| 2021 | -0.13 CAD | -314.01% |
| 2020 | -0.03 CAD | 71.45% |
| 2019 | -0.11 CAD | 38.89% |
| 2018 | -0.18 CAD | -298.23% |
| 2017 | -0.05 CAD | 22.74% |
| 2016 | -0.06 CAD | 46.82% |
| 2015 | -0.11 CAD | -54.93% |
| 2014 | -0.07 CAD | 1.53% |
| 2013 | -0.07 CAD | 89.08% |
| 2012 | -0.66 CAD | -164.0% |
| 2011 | -0.25 CAD | -47.06% |
| 2010 | -0.17 CAD | -648.9% |
| 2009 | -0.02 CAD | -100.88% |
| 2008 | -0.01 CAD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | -0.01 CAD | 13.59% |
| 2024 Q1 | -0.01 CAD | 40.8% |
| 2023 Q3 | -0.01 CAD | -32.39% |
| 2023 FY | - CAD | -11.11% |
| 2023 Q1 | -0.01 CAD | 60.71% |
| 2023 Q2 | -0.01 CAD | -29.09% |
| 2023 Q4 | -0.02 CAD | -85.11% |
| 2022 Q4 | -0.01 CAD | -150.0% |
| 2022 Q1 | -0.01 CAD | 90.82% |
| 2022 Q2 | -0.01 CAD | 11.88% |
| 2022 FY | - CAD | 71.62% |
| 2022 Q3 | -0.01 CAD | 37.08% |
| 2021 FY | - CAD | -314.01% |
| 2021 Q1 | 0.00 CAD | 115.09% |
| 2021 Q2 | -0.01 CAD | -481.25% |
| 2021 Q3 | -0.01 CAD | -37.7% |
| 2021 Q4 | -0.11 CAD | -1209.52% |
| 2020 FY | - CAD | 71.45% |
| 2020 Q2 | -0.01 CAD | 10.94% |
| 2020 Q3 | -0.01 CAD | -15.79% |
| 2020 Q4 | -0.01 CAD | -60.61% |
| 2020 Q1 | -0.01 CAD | 50.0% |
| 2019 FY | - CAD | 38.89% |
| 2019 Q4 | -0.01 CAD | 67.35% |
| 2019 Q1 | -0.04 CAD | 68.62% |
| 2019 Q3 | -0.04 CAD | -226.67% |
| 2019 Q2 | -0.01 CAD | 70.59% |
| 2018 Q2 | -0.01 CAD | 85.42% |
| 2018 Q1 | -0.06 CAD | -89.88% |
| 2018 FY | - CAD | -298.23% |
| 2018 Q3 | -0.02 CAD | -66.67% |
| 2018 Q4 | -0.13 CAD | -738.71% |
| 2017 Q2 | -0.02 CAD | -342.59% |
| 2017 Q1 | -0.01 CAD | -10.2% |
| 2017 Q4 | -0.03 CAD | -92.0% |
| 2017 Q3 | -0.02 CAD | 26.78% |
| 2017 FY | - CAD | 22.74% |
| 2016 Q2 | -0.02 CAD | -1125.0% |
| 2016 FY | - CAD | 46.82% |
| 2016 Q3 | -0.02 CAD | 18.37% |
| 2016 Q4 | -0.00 CAD | 69.38% |
| 2016 Q1 | -0.00 CAD | 92.31% |
| 2015 Q2 | -0.02 CAD | -36.72% |
| 2015 Q4 | -0.02 CAD | -41.5% |
| 2015 FY | - CAD | -54.93% |
| 2015 Q3 | -0.01 CAD | 16.0% |
| 2015 Q1 | -0.01 CAD | -18.52% |
| 2014 Q4 | -0.01 CAD | 64.59% |
| 2014 Q1 | -0.08 CAD | -162.71% |
| 2014 FY | - CAD | 1.53% |
| 2014 Q3 | -0.03 CAD | -176.25% |
| 2014 Q2 | 0.04 CAD | 150.25% |
| 2013 FY | - CAD | 89.08% |
| 2013 Q4 | -0.03 CAD | -150.41% |
| 2013 Q3 | -0.01 CAD | 21.94% |
| 2013 Q2 | -0.02 CAD | -66.67% |
| 2013 Q1 | -0.01 CAD | 74.17% |
| 2012 Q1 | -0.12 CAD | -91.69% |
| 2012 Q4 | -0.04 CAD | -218.58% |
| 2012 Q2 | -0.46 CAD | -283.33% |
| 2012 FY | - CAD | -164.0% |
| 2012 Q3 | -0.01 CAD | 97.54% |
| 2011 Q2 | -0.14 CAD | -400.0% |
| 2011 Q3 | -0.02 CAD | 86.5% |
| 2011 Q4 | -0.06 CAD | -231.22% |
| 2011 FY | - CAD | -47.06% |
| 2011 Q1 | -0.03 CAD | 38.73% |
| 2010 Q2 | -0.02 CAD | -72.92% |
| 2010 Q1 | -0.01 CAD | 86.91% |
| 2010 FY | - CAD | -648.9% |
| 2010 Q4 | -0.05 CAD | -13.4% |
| 2010 Q3 | -0.04 CAD | -61.85% |
| 2009 Q3 | -0.02 CAD | -143.28% |
| 2009 FY | - CAD | -100.88% |
| 2009 Q1 | -0.00 CAD | 39.71% |
| 2009 Q4 | -0.11 CAD | -574.85% |
| 2009 Q2 | -0.01 CAD | -63.41% |
| 2008 Q3 | -0.02 CAD | 0.0% |
| 2008 Q4 | -0.01 CAD | 54.97% |
| 2008 FY | - CAD | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Algernon Pharmaceuticals Inc. | -0.45 CAD | 90.889% |
| Asep Medical Holdings Inc | -0.13 CAD | 68.462% |
| BetterLife Pharma Inc. | -0.03 CAD | -55.303% |
| BioVaxys Technology Corp. | -0.06 CAD | 28.447% |
| ChitogenX Inc. | -0.02 CAD | -92.488% |
| Defence Therapeutics Inc. | -0.30 CAD | 86.333% |
| Entheon Biomedical Corp. | -0.05 CAD | 19.291% |
| Gemina Laboratories Ltd. | -0.07 CAD | 43.056% |
| Glow Lifetech Corp. | -0.03 CAD | -42.361% |
| Lexston Life Sciences Corp. | -0.02 CAD | -78.261% |
| Pharmala Biotech Holdings Inc. | -0.01 CAD | -345.652% |
| Doseology Sciences Inc. | -0.08 CAD | 48.557% |
| MYND Life Sciences Inc. | -0.03 CAD | -27.726% |
| Nova Mentis Life Science Corp. | -0.01 CAD | -393.976% |
| PharmaTher Holdings Ltd. | -0.04 CAD | -16.147% |
| PreveCeutical Medical Inc. | -0.00 CAD | -1608.333% |
| Telescope Innovations Corp. | -0.12 CAD | 65.833% |